BioNTech SE Impairment Loss Recognised In Other Comprehensive Income Rightofuse Assets
BioNTech SE (BNTX) reported Impairment Loss Recognised In Other Comprehensive Income Rightofuse Assets of EUR 13.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeRightofuseAssets · last filed 2026-03-10
| Period end | Impairment Loss Recognised In Other Comprehensive Income Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | 13.80M EUR 20-F · filed 2026-03-10 |